Healthcare provider profile · identity verified

Debra Klinger

Nurse Practitioner · VICKSBURG, MI · NPI 1346607447

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	369	99
Levothyroxine Sodium	Levothyroxine Sodium	315	81
Lisinopril	Lisinopril	299	72
Omeprazole	Omeprazole	260	70
Rosuvastatin Calcium	Rosuvastatin Calcium	240	77
Amlodipine Besylate	Amlodipine Besylate	188	52
Metoprolol Succinate	Metoprolol Succinate	173	38
Hydrochlorothiazide	Hydrochlorothiazide	156	52
Gabapentin	Gabapentin	148	31
Metformin Hcl Er	Metformin Hcl	132	34
Sertraline Hcl	Sertraline Hcl	125	31
Metformin Hcl	Metformin Hcl	122	31
Alprazolam	Alprazolam	121	40
Pantoprazole Sodium	Pantoprazole Sodium	115	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	34
Furosemide	Furosemide	98	28
Tamsulosin Hcl	Tamsulosin Hcl	96	25
Losartan Potassium	Losartan Potassium	94	24
Famotidine	Famotidine	92	25
Simvastatin	Simvastatin	89	27
Albuterol Sulfate Hfa	Albuterol Sulfate	88	37
Escitalopram Oxalate	Escitalopram Oxalate	86	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	22
Jardiance	Empagliflozin	82	19
Prednisone	Prednisone	77	56
Duloxetine Hcl	Duloxetine Hcl	64	15
Fluoxetine Hcl	Fluoxetine Hcl	64	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	64	18
Venlafaxine Hcl Er	Venlafaxine Hcl	64	12
Carvedilol	Carvedilol	62	14
Allopurinol	Allopurinol	59	14
Glipizide Er	Glipizide	59	16
Topiramate	Topiramate	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	23
Pravastatin Sodium	Pravastatin Sodium	56	17
Montelukast Sodium	Montelukast Sodium	54	13
Fenofibrate	Fenofibrate	52	13
Celecoxib	Celecoxib	48	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	47	17
Estradiol	Estradiol	46	17
Trazodone Hcl	Trazodone Hcl	46	15
Meloxicam	Meloxicam	44	15
Tramadol Hcl	Tramadol Hcl	44	15
Citalopram Hbr	Citalopram Hydrobromide	43	11
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Nystatin	Nystatin	42	18
Potassium Chloride	Potassium Chloride	42	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	15
Clonazepam	Clonazepam	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	29
Buspirone Hcl	Buspirone Hcl	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	11
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Azithromycin	Azithromycin	28	27
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Eliquis	Apixaban	28	14
Ezetimibe	Ezetimibe	27	suppressed
Ibuprofen	Ibuprofen	27	11
Atenolol	Atenolol	26	suppressed
Colestipol Hcl	Colestipol Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	25	22
Trulicity	Dulaglutide	25	suppressed
Ozempic	Semaglutide	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	21
Mirtazapine	Mirtazapine	22	suppressed
Torsemide	Torsemide	22	suppressed
Mounjaro	Tirzepatide	21	suppressed
Baclofen	Baclofen	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Finasteride	Finasteride	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	20	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	19	suppressed
Diazepam	Diazepam	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Naproxen	Naproxen	17	11
Carbamazepine	Carbamazepine	16	suppressed
Colchicine	Colchicine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Cephalexin	Cephalexin	15	14
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Glipizide	Glipizide	15	suppressed
Ramipril	Ramipril	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Lovastatin	Lovastatin	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error